Cargando…

Xyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates in Caenorhabditis elegans model of Huntington’s disease

Huntington’s disease is an autosomal-dominant neurodegenerative disorder, with chorea as the most prominent manifestation. The disease is caused by abnormal expansion of CAG codon repeats in the IT15 gene, which leads to the expression of a glutamine-rich protein named mutant Huntingtin (Htt). Becau...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Yixuan, Guo, Wenyuan, Xu, Guangqing, Wang, Qinmei, Feng, Luyang, Long, Simei, Liang, Fengyin, Huang, Yi, Lu, Xilin, Li, Shichang, Zhou, Jiebin, Burgunder, Jean-Marc, Pang, Jiyan, Pei, Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835117/ https://www.ncbi.nlm.nih.gov/pubmed/27110099 http://dx.doi.org/10.2147/DDDT.S94666

Ejemplares similares

Synthesis and Neuroprotective Action of Xyloketal Derivatives in Parkinson’s Disease Models
por: Li, Shichang, et al.
Publicado: (2013)

Xyloketal derivative C53N protects against mild traumatic brain injury in mice
por: Liang, Fengyin, et al.
Publicado: (2018)

Chemical mutagenesis of Caenorhabditis elegans uncovers genetic modifiers of huntingtin protein aggregation
por: Ung, Hailey M., et al.
Publicado: (2020)

Huntingtin Aggregates in the Olfactory Bulb in Huntington’s Disease
por: Highet, Blake, et al.
Publicado: (2020)

Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin
por: Tan, Z, et al.
Publicado: (2015)

A new Caenorhabditis elegans model of human huntingtin 513 aggregation and toxicity in body wall muscles
por: Lee, Amy L., et al.
Publicado: (2017)

Embryonic Mutant Huntingtin Aggregate Formation in Mouse Models of Huntington’s Disease
por: Osmand, Alexander P., et al.
Publicado: (2016)

High expression levels of the D686N Parkinson's disease mutation in VPS35 induces α-synuclein-dependent toxicity in yeast
por: Huang, Yi, et al.
Publicado: (2017)

Modifiers of mutant huntingtin aggregation: functional conservation of C. elegans-modifiers of polyglutamine aggregation
por: Teuling, Eva, et al.
Publicado: (2011)

TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease models
por: Hegde, Ramanath Narayana, et al.
Publicado: (2020)

Osmolytes dynamically regulate mutant Huntingtin aggregation and CREB function in Huntington’s disease cell models
por: Aravindan, Shreyaas, et al.
Publicado: (2020)

Siah-1-interacting protein regulates mutated huntingtin protein aggregation in Huntington’s disease models
por: Latoszek, Ewelina, et al.
Publicado: (2022)

Design and Synthesis of Novel Xyloketal Derivatives and Their Protective Activities against H(2)O(2)-Induced HUVEC Injury
por: Liu, Shixin, et al.
Publicado: (2015)

Emerging Therapies for Huntington’s Disease – Focus on N-Terminal Huntingtin and Huntingtin Exon 1
por: van der Bent, M Leontien, et al.
Publicado: (2022)

Subcellular Localization And Formation Of Huntingtin Aggregates Correlates With Symptom Onset And Progression In A Huntington’S Disease Model
por: Landles, Christian, et al.
Publicado: (2020)

Identification of Potential Therapeutic Drugs for Huntington's Disease using Caenorhabditis elegans
por: Voisine, Cindy, et al.
Publicado: (2007)

Xyloketal B Attenuates Fatty Acid-Induced Lipid Accumulation via the SREBP-1c Pathway in NAFLD Models
por: Zhang, Youying, et al.
Publicado: (2017)

G2019S LRRK2 Increases Stress Susceptibility Through Inhibition of DAF-16 Nuclear Translocation in a 14-3-3 Associated-Manner in Caenorhabditis elegans
por: Long, Simei, et al.
Publicado: (2018)

Phosphorylation of huntingtin at residue T3 is decreased in Huntington’s disease and modulates mutant huntingtin protein conformation
por: Cariulo, Cristina, et al.
Publicado: (2017)

The Aggregation of Huntingtin and α-Synuclein
por: Chánez-Cárdenas, María Elena, et al.
Publicado: (2012)

The Novel Alpha-2 Adrenoceptor Inhibitor Beditin Reduces Cytotoxicity and Huntingtin Aggregates in Cell Models of Huntington’s Disease
por: Singer, Elisabeth, et al.
Publicado: (2021)

Age-dependent accumulation of tau aggregation in Caenorhabditis elegans
por: Aquino Nunez, Wendy, et al.
Publicado: (2022)

Marine Compound Xyloketal B Reduces Neonatal Hypoxic-Ischemic Brain Injury
por: Xiao, Ai-Jiao, et al.
Publicado: (2014)

Marine Compound Xyloketal B as a Potential Drug Development Target for Neuroprotection
por: Gong, Haifan, et al.
Publicado: (2018)

Making (anti-) sense out of huntingtin levels in Huntington disease
por: Evers, Melvin M, et al.
Publicado: (2015)

Salivary levels of total huntingtin are elevated in Huntington’s disease patients
por: Corey-Bloom, Jody, et al.
Publicado: (2018)

Recent Trends in Detection of Huntingtin and Preclinical Models of Huntington's Disease
por: Mantha, Neelima, et al.
Publicado: (2014)

Huntingtin-interacting protein family members have a conserved pro-viral function from Caenorhabditis elegans to humans
por: Jiang, Hongbing, et al.
Publicado: (2020)

Ubiquilin-1 Overexpression Increases the Lifespan and Delays Accumulation of Huntingtin Aggregates in the R6/2 Mouse Model of Huntington's Disease
por: Safren, Nathaniel, et al.
Publicado: (2014)

A C-terminal ataxin-2 disordered region promotes Huntingtin protein aggregation and neurodegeneration in Drosophila models of Huntington’s disease
por: Huelsmeier, Joern, et al.
Publicado: (2021)

Small, Seeding-Competent Huntingtin Fibrils Are Prominent Aggregate Species in Brains of zQ175 Huntington’s Disease Knock-in Mice
por: Schindler, Franziska, et al.
Publicado: (2021)

Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington’s disease
por: Bertoglio, Daniele, et al.
Publicado: (2021)

Huntington’s Disease: From Mutant Huntingtin Protein to Neurotrophic Factor Therapy
por: Sari, Youssef
Publicado: (2011)

A Fresh Look at Huntingtin mRNA Processing in Huntington’s Disease
por: Romo, Lindsay, et al.
Publicado: (2018)

Rac1 Activity Is Modulated by Huntingtin and Dysregulated in Models of Huntington’s Disease
por: Tousley, Adelaide, et al.
Publicado: (2019)

Polyglutamine expansion affects huntingtin conformation in multiple Huntington’s disease models
por: Daldin, Manuel, et al.
Publicado: (2017)

Huntington’s Disease Protein Huntingtin Associates with its own mRNA
por: Culver, Brady P., et al.
Publicado: (2016)

Analysis of mutant and total huntingtin expression in Huntington’s disease murine models
por: Fodale, Valentina, et al.
Publicado: (2020)

Soluble mutant huntingtin drives early human pathogenesis in Huntington’s disease
por: Miguez, Andrés, et al.
Publicado: (2023)

Salivary Huntingtin protein is uniquely associated with clinical features of Huntington’s disease
por: Parkin, Georgia M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_36cjsuijvvaj4qj4actvdejev4